Calico Biosystems is a Swiss startup that is redefining the development of cancer drugs. With 95% of cancer drugs failing due to outdated preclinical models, we offer a breakthrough approach: the company test on real tumors, achieve unmatched precision through our algorithm, and enable global access through proprietary cryopreservation. By partnering with Calico Biosystems, pharmaceutical and biotech companies can reduce development costs, accelerate time to market, and double their chances of clinical success – bringing life-changing therapies to patients faster.
Calico Biosystems combines 3 core innovations that shift from trial-and-error to predictive drug development built on data-driven tumor biology:
Calico Biosystems
Alanine Building – StartLab
Route de la Corniche 5A
1066 Epalinges
Keywords
